Endpoints in studies on myocardial infarction

Lancet

Volumn 369, Issue 9571, 2007, Pages 1430-

  Lapostolle, F ^a   Catineau, J ^a   Lapandry, C ^a   Adnet, F ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PLACEBO;

ANGIOCARDIOGRAPHY; CONGESTIVE HEART FAILURE; DEATH; HEART INFARCTION; HEART REINFARCTION; HUMAN; ISCHEMIA; LETTER; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SHOCK; ST SEGMENT ELEVATION; STROKE;

EID: 34247359854     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60667-9     Document Type: Letter

References (5)

1. The ISIS 2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988) 349-360
2. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
3. Andersen H., Nielsen T., Rasmussen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
4. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367 (2006) 569-578
5. Sabatine M., Cannon C., Gibson C., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189